Möchten Sie immer auf dem neuesten Stand bleiben?

MajesTEC-9 is the second positive Phase 3 study to reinforce the strength of Johnson & Johnson’s TECVAYLI® as early as second line1TECVAYLI® delivered deep and durable responses, with nearly...

Brain tissue oxygenation in early stage of stroke with BXT-25 is monitored in real time  BOSTON, MASSACHUSETTS, May 29, 2026 (GLOBE NEWSWIRE) -- Bioxytran Inc. (OTCQB: BIXT), a biotechnology...

Global Smart Meter Market Size, Share, Trends & Segmentation, By Component, Type, Technology, Communication Technology, End-User and Forecast 2026–2035

BPM31510 is a first-in-class therapeutic targeting tumor metabolism to re-program mitochondrial microenvironment in Warburg-avid tumorsBoth safety profile and efficacy data to be highlighted in...

Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease Paris, May 28, 2026. The US Food and Drug Administration (FDA) has granted priority review to the new drug...

Broad-spectrum antiviral agent with potential utility against Hantavirus, Ebola and Lassa Utilizing a novel dual-strike mechanism, the proprietary combination agent has the potential to deliver a low...

Global Smartwatch Market Size, Share, Trends & Segmentation By Product Type, Operating System, Display Type, Application, End-User & Forecast 2026-2035

Third Quarter Highlights Revenue grew 25% year-over-year to $850.5 millionAnnual Recurring Revenue (ARR) grew 25% year-over-year to $3,525 millionOperating cash flow of $198.0 million, compared to...

Fully enrolled, randomized, double-blind, sham-controlled Phase 2 study has completed treatment administration in 99 patients; Company continues Phase 3 readiness activities following FDA Type B...

- Dialysis access requires frequent cannulation, often exceeding 300 needle punctures annually -  - The ATEV was observed to maintain long-term structural integrity and self-repair with smooth muscle...